Ethical Aspect of Industry-Sponsored Psychopharmacological Research.
- Author:
Kyung Ryeol CHA
1
;
Chan Hyung KIM
Author Information
1. Department of Psychiatry, College of Medicine, Yonsei University, Seoul, Korea. spr88@yumc.yonsei.ac.kr
- Publication Type:Review
- Keywords:
Ethics;
Industry;
Informed consent;
Psychopharmaceuticals;
Clinical research
- MeSH:
Commerce;
Conflict of Interest;
Drug Industry;
Ethics;
Informed Consent;
Psychiatry;
Psychotropic Drugs
- From:Journal of Korean Neuropsychiatric Association
2006;45(6):505-510
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Psychiatrists and pharmaceutical industry have a shared interest in advancing medical knowledge. Nonetheless, they also create opportunities for conflict of interests. The primary interest of the psychiatrist is to promote the patient's best interests, while the primary interest of industry is to promote profitability. This paper explores the content of ethical documents most relevant to the biomedical researcher and guidelines related to the ethics of sponsored research. Subsequently, it discusses the ethical quandaries involved and offers solutions for ethical business relationships.
